Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene

Doc number: O50

Saved in:

Bibliographic Details
Published in:	Retrovirology Vol. 9; no. S2; p. O50
Main Authors:	O'Connell, RJ, Polonis, VR, Ratto-Kim, S, Cox, J, Jagodzinski, LL, Malia, J, Michael, NL, Excler, J, Robb, ML, Kim, JH
Format:	Journal Article
Language:	English
Published:	London BioMed Central 13-09-2012 BioMed Central Ltd BMC
Subjects:	Acquired immune deficiency syndrome AIDS HIV Human immunodeficiency virus Immunization Oral Presentation Proteins Vaccines
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!